Display options
Share it on

J Ginseng Res. 2013 Mar;37(1):45-53. doi: 10.5142/jgr.2013.37.45.

Red ginseng extract protects against carbon tetrachloride-induced liver fibrosis.

Journal of ginseng research

Sung Hwan Ki, Ji Hye Yang, Sae Kwang Ku, Sang Chan Kim, Young Woo Kim, Il Je Cho

Affiliations

  1. College of Pharmacy, Chosun University, Gwangju 501-759, Korea.

PMID: 23717156 PMCID: PMC3659625 DOI: 10.5142/jgr.2013.37.45

Abstract

Korean red ginseng, the processed root of Panax ginseng Meyer, has been frequently used for various therapeutic purposes in oriental medicine. The present study investigated the possible effect of Korean red ginseng extract (RGE) for the treatment of liver fibrosis in mice injected with carbon tetrachloride (CCl4) for 4 wk. Liver injuries were assessed by blood biochemistry and histopathology in mice treated with CCl4 alone or CCl4+ RGE (30, 100, and 300 mg/kg). Concomitant treatment with RGE and CCl4 (three times/wk for 4 wk) effectively inhibited liver fibrosis as evidenced by decreases in plasma alanine and aspartate aminotransferases, as well as by the percentages of degenerative regions, numbers of degenerative hepatocytes, and collagen accumulation in hepatic parenchyma. Treatment with CCl4 for 4 wk increased mRNA levels of transforming growth factor β1 and plasminogen activator inhibitor 1 in fibrogenic liver, whereas RGE (30, 100, and 300 mg/kg) significantly blocked the induction of fibrogenic genes by CCl4. Similarly, RGE also prevented transforming growth factor β1-mediated induction of fibrogenic genes in human hepatic stellate cell lines. More importantly, RGE markedly reduced the number of α-smooth muscle actin-positive cells in liver tissue. This study implies that RGE efficaciously protects against the liver fibrosis induced by chronic CCl4 treatment, and may therefore have potential to treat liver disease.

Keywords: Korean red ginseng; Liver fibrosis; Panax ginseng; Transforming growth factor β1; α-smooth muscle actin

References

  1. J Biol Chem. 1987 Feb 5;262(4):1652-8 - PubMed
  2. Gastroenterology. 2008 May;134(6):1655-69 - PubMed
  3. J Ginseng Res. 2011 Nov;35(4):457-61 - PubMed
  4. FASEB J. 2002 Dec;16(14):1988-90 - PubMed
  5. Cytokine. 2006 Sep;35(5-6):284-94 - PubMed
  6. Am J Pathol. 1998 Aug;153(2):515-25 - PubMed
  7. J Pharmacol Sci. 2004 Jun;95(2):158-62 - PubMed
  8. Am J Chin Med. 2008;36(5):989-1004 - PubMed
  9. Hepatology. 1983 Jan-Feb;3(1):112-20 - PubMed
  10. J Med Food. 2011 Oct;14(10):1135-43 - PubMed
  11. J Cell Mol Med. 2006 Jan-Mar;10(1):76-99 - PubMed
  12. Hepatology. 2010 Dec;52(6):2053-64 - PubMed
  13. Thromb Haemost. 1996 May;75(5):801-7 - PubMed
  14. Hepatology. 2008 Feb;47(2):668-76 - PubMed
  15. J Ginseng Res. 2011 Sep;35(3):315-24 - PubMed
  16. Chem Biol Interact. 2011 Nov 15;194(2-3):106-12 - PubMed
  17. Am J Pathol. 2007 Jun;170(6):1807-16 - PubMed
  18. Cytokine. 1999 Feb;11(2):179-85 - PubMed
  19. EMBO J. 1998 Jun 1;17(11):3091-100 - PubMed
  20. J Cell Physiol. 2012 Mar;227(3):1081-9 - PubMed
  21. J Clin Invest. 2005 Feb;115(2):209-18 - PubMed
  22. Eur J Pharmacol. 2010 May 25;634(1-3):162-9 - PubMed
  23. Environ Toxicol Pharmacol. 2010 Sep;30(2):134-40 - PubMed
  24. Dig Dis Sci. 1991 Jul;36(7):962-72 - PubMed
  25. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2007 Jul-Sep;25(3):185-209 - PubMed
  26. BMC Gastroenterol. 2010 Jul 09;10:79 - PubMed
  27. Int J Mol Sci. 2012;13(5):5729-39 - PubMed
  28. Thromb Res. 2003;111(4-5):301-9 - PubMed
  29. Gastroenterology. 2007 Jun;132(7):2557-76 - PubMed
  30. Metabolism. 2009 Aug;58(8):1170-7 - PubMed
  31. Clin Chem. 1978 Nov;24(11):1971-9 - PubMed

Publication Types